Skip to main content

Table 1 Characteristics of Patients Aged 18 Years and Above with a Diagnosis of Advanced Stage (T4) Oral Cavity Squamous Cell Carcinoma, by Insurance Status, 2007 to 2016

From: The effect of insurance status on treatment modality in advanced oral cavity cancer

Characteristic

Total

Insured

Medicaid

Uninsured

P-value

n = 2,628

n = 1,915

n = 561

n = 152

Sex, n (%)

Male

1,670 (63.55)

1,196 (62.45)

368 (65.60)

106 (69.74)

0.03

Female

958 (36.45)

719 (37.55)

193 (34.40)

46 (30.26)

Age, n (%)

18–29

12 (0.47)

8 (0.43)

2 (0.36)

2 (1.32)

 < 0.0001

30–59

889 (34.63)

483 (26.00)

294 (52.78)

112 (73.68)

60–79

1,241 (48.34)

997 (53.66)

206 (36.98)

38 (25.00)

 > 80

425 (16.56)

370 (19.91)

55 (9.87)

Age Mean, (SD)

66 (13.59)

68.39 (13.34)

61.27 (12.54)

53.39 (7.69)

Year of diagnosis

2007

179 (6.81)

131 (6.84)

35 (6.24)

13 (8.55)

0.06

2008

231 (8.79)

161 (8.41)

57 (10.16)

13 (8.55)

2009

270 (10.27)

199 (10.39)

54 (9.63)

17 (11.18)

2010

280 (10.65)

208 (10.86)

49 (8.73)

23 (15.13)

2011

322 (12.25)

225 (11.75)

76 (13.55)

21 (13.82)

2012

303 (11.53)

224 (11.70)

55 (9.80)

24 (15.79)

2013

360 (13.70)

266 (13.89)

77 (13.73)

17 (11.18)

2014

348 (13.24)

244 (12.74)

92 (16.40)

12 (7.89)

2015

335 (12.75)

257 (13.42)

66 (11.76)

12 (7.89)

Marital status, n (%)

Married

1,145 (43.57)

937 (48.93)

162 (28.88)

46 (30.26)

 < 0.0001

Unmarried

541 (20.59)

279 (14.57)

198 (35.29)

64 (42.11)

Separated, Divorced, or Widowed

799 (30.40)

596 (31.12)

166 (29.59)

37 (24.34)

Unknown

143 (5.44)

103 (5.38)

35 (6.24)

5 (3.29)

Race, n (%)

White

2,090 (79.53)

1,593 (83.19)

392 (69.88)

105 (69.08)

 < 0.0001

Black

317 (12.06)

176 (9.19)

102 (18.18)

39 (25.66)

American Indian, Native American, or Hawaiian

34 (1.29)

19 (0.99)

15 (2.67)

Chinese

23 (0.88)

14 (0.73)

9 (1.60)

Japanese

27 (1.03)

26 (1.36)

1 (0.18)

Filipino

20 (0.76)

16 (0.84)

3 (0.53)

1 (0.66)

Asian Indian or Pakistani

64 (2.44)

41 (2.14)

20 (3.57)

3 (1.97)

Other

51 (1.94)

28 (1.46)

19 (3.39)

4 (2.63)

Unknown

2 (0.08)

2 (0.10)

Primary site, n (%)

Mucosal lips

18 (0.68)

14 (0.73)

4 (0.71)

 < 0.0001

Oral tongue

763 (29.03)

522 (27.26)

182 (32.44)

59 (38.82)

Alveolar ridge

634 (24.12)

527 (27.52)

89 (15.86)

18 (11.84)

Floor of mouth

604 (22.98)

392 (20.47)

166 (29.59)

46 (30.26)

Palate

195 (7.42)

161 (8.41)

29 (5.17)

5 (3.29)

Buccal mucosa

226 (8.60)

154 (8.04)

57 (10.16)

15 (9.87)

Overlapping or NOS

188 (7.15)

145 (7.57)

34 (6.06)

9 (5.92)

T Stage

T4a

2,365 (88.88)

1,709 (89.24)

496 (88.41)

131 (86.18)

 < 0.0001

T4b

227 (8.53)

152 (7.94)

53 (9.45)

19 (12.50)

T4 NOS

69 (2.59)

54 (2.82)

12 (2.14)

2 (1.32)

Treatment

Definitive

1,015 (38.62)

772 (40.31)

191 (34.05)

52 (34.21)

0.014

Non-definitive

1,613 (61.38)

1,143 (59.69)

370 (65.95)

100 (65.79)